Former British Prime Minister David Cameron has announced his full recovery from prostate cancer after undergoing treatment.
In an interview with “The Times,” Cameron revealed details of his health condition and indicated that his sharing of his experience comes as part of his support for a national campaign aimed at expanding early detection programs for the disease.
Cameron, 59, who served as Prime Minister between 2010 and 2016, in addition to recently holding the position of Foreign Secretary, has joined prominent figures such as Olympic champion Sir Chris Hoy and former Prime Minister Rishi Sunak in calling for improved screening and treatment mechanisms.
Beginning of Diagnosis:
Cameron reported that he went to his private doctor for a prostate-specific antigen (PSA) test at the urging of his wife, Samantha, and the results showed a worrying increase in antigen levels.
Subsequently, he underwent a biopsy that confirmed the diagnosis, describing this moment as “a difficult, unforgettable moment,” and confirmed that he decided to proceed with treatment immediately instead of waiting.
Cameron chose focal therapy, an approach that relies on directing precise electrical pulses through needles to destroy cancer cells.
He also joked that his MRI scan coincided with the period when the United States was discussing assessing the damage of a nuclear bombing in Iran, commenting: “I had my own bomb damage assessment.”
Cameron recalled a painful personal experience with the death of his older brother, Alexander, from pancreatic cancer at the same age, and confirmed that this was a motivation for making a quick treatment decision.
Call for Early Screening:
Cameron explained that his public announcement aims to exploit his public platform to raise awareness, saying: “I want to add my voice to those calling for a targeted screening program.”
He also affirmed his support for the Prostate Cancer Research Association, which is striving to introduce periodic checkups for men most at risk.
Cameron added: “Men usually don’t talk about their health, and postpone checkups, especially when it comes to the prostate, which is related to sexual health. But my experience has proven that early screening can save a life.”
Statistics indicate that about 12,000 men die annually in the United Kingdom from prostate cancer, making it the most common type of cancer among men.
A research trial is currently underway to study how to integrate the PSA test with other assessments to improve screening accuracy.
Cameron’s statements come ahead of an upcoming meeting of the National Screening Committee, where it is expected to give the green light to the first official prostate cancer screening program within the National Health Service.
